Ironwood Pharmaceuticals | IRWD - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Almirall EUR 323.65M 26.99M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amarin USD 164.2M 15.45M 2026-06
Ardelyx USD 109.57M 20.96M 2026-03
Astellas Pharma JPY 1.23T 16.36B 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Coherus Biosciences USD 75.51M 56.82M 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Incyte USD 1.31B 177.55M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
Moderna USD 2.53B 139M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Pacira USD 122.01M 13.22M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Takeda JPY 2.76T 335.02B 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12